[New molecules in 2002].
Vervaeren
J
J
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004358:Drug Therapy / Q000639:trends*; D057487:Enzyme Therapy; D005060:Europe; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D004364:Pharmaceutical Preparations; D011994:Recombinant Proteins / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D017320:HIV Protease Inhibitors; D004364:Pharmaceutical Preparations; D011994:Recombinant Proteins